Skip to main content

Advertisement

Log in

Development and validation of a novel nomogram for postoperative overall survival of patients with primary gastric signet-ring cell carcinoma: a population study based on SEER database

  • Research
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Gastric signet ring cell carcinoma (GSRCC) is a highly malignant subtype of gastric cancer. We tried to establish and validate a nomogram using common clinical variables to achieve more personalized management.

Methods

We analyzed patients with GSRCC in the Surveillance, Epidemiology, and End Results database between 2004 and 2017. The survival curve was calculated by the Kaplan–Meier method, and the difference in survival curve was tested by log-rank test. We used the cox proportional hazard model to evaluate independent factors of prognosis, and established a nomogram to predict 1-, 3- and 5- overall survival (OS). Harrell's consistency index and calibration curve were used to measure the discrimination and calibration of the nomogram. In addition, we used decision curve analysis (DCA) to compare the net clinical benefits of the nomogram and American Joint Committee on Cancer (AJCC) staging system.

Results

The prognosis nomogram predicting 1-, 3- and 5-years OS for patients with GSRCC is established for the first time. The C-index and AUC of nomogram were higher than that of the American Joint Committee on Cancer (AJCC) staging system in the training set. Our model also shows better performance than the AJCC staging system in the validation set, and importantly, DCA shows that our model has a better net benefit than the AJCC stage.

Conclusions

We have developed and validated a new nomogram and risk classification system, which is better than the AJCC staging system. It will help clinicians manage postoperative patients with GSRCC more accurately.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Availability of data and materials

SEER Stat 8.39 software was used to extract our data online, and data in our study is available at SEER database: https://seer.cancer.gov/.

Abbreviations

GSRCC:

Gastric signet ring cell carcinoma

SEER:

Surveillance, Epidemiology, and End Results

OS:

Overall survival

RNE:

Regional nodes examined

AJCC:

American Joint Committee on Cancer

DCA:

Decision curve analysis

NA:

Not available

CI:

Confidence interval

References

Download references

Acknowledgements

The authors would like to express their gratitude to SEER for providing free access to the database.

Funding

The study was supported by Key project of Hunan Provincial Health Commission (C202203108338), 2021 Hunan Clinical Medical Technology Innovation Guidance Project (2021SK51410), the scientific research fund of Guangdong EFONG Pharmaceutical Co., Ltd (2022YF10) and Graduate Student Innovation Project of Hunan University of Chinese Medicine (2022CX22).

Author information

Authors and Affiliations

Authors

Contributions

DR N and J L conceived and designed the study. DR N and GL A wrote the manuscript. DR N, H Z collected data and performed the statistical analysis. J L and DR N revised the manuscript. All authors read and approved the submitted version.

Corresponding author

Correspondence to Jing Li.

Ethics declarations

Conflict of Interest

The authors claim that there were no potential conflicts of interest in the study due to business or financial relationships.

Ethics approval and consent to participate

Since the patient information in the SEER database is deidentified and publicly available, our study was exempt from Institutional Review Board approval. In addition, we declared all methods were carried out in accordance with relevant guidelines and regulations.

Consent for publication

Each author agreed to publish the paper.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

432_2023_4796_MOESM1_ESM.pdf

Supplementary figure 1 The optimal cutoff values for age (A/B), number of regional lymph nodes examined (C/D), and tumor size (E/F) were shown by X-tile analysis

Supplementary figure 2 The optimal cutoff values for risk score were shown by X-tile analysis

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nie, D., Zheng, H., An, G. et al. Development and validation of a novel nomogram for postoperative overall survival of patients with primary gastric signet-ring cell carcinoma: a population study based on SEER database. J Cancer Res Clin Oncol 149, 8593–8603 (2023). https://doi.org/10.1007/s00432-023-04796-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-023-04796-x

Keywords

Navigation